A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing-like sarcomas
Administered By
Awarded By
Contributors
- Riedel, Richard Francis Principal Investigator
Start/End
- February 1, 2014 - July 13, 2021